The addition of daratumumab to lenalidomide and dexamethasone resulted in a significant benefit to overall survival in patients with newly diagnosed multiple myeloma who were ineligible for autologous stem cell transplant and were treated to progression, according to the results of the phase 3 MAIA study.
A contraception toolkit helps them improve women's reproductive health.
The condition is not preventable, but there are steps that can be taken to reduce LDL-C levels in children.
In the United States, endometrial cancer is the most common cancer of female reproductive organs.
A 300 mg dose is currently available with a prescription.
The study authors said this research is the first systematic review that compares treatments for depression in those with coronary disease.
Owner Nancy Peterson enjoys taking care of patients, accompanied by popular sidekick Rosie the Rabbiter.
The "human first" health company is the first virtual specialized care company to partner with the publication.
Results from part A of a phase 3 trial showed sutimlimab caused patients to experience a rapid and sustained inhibition of C1-activated hemolysis in patients with cold agglutinin disease.
Researchers observed the structure of a lethal toxin produced by certain strains of Clostridium difficile bacteria.
New protocol for processing saliva samples with a bead mill homogenizer before real-time PCR testing has shown higher sensitivity to COVID-19 than nasopharyngeal swab testing
The study examining venetoclax and obinutuzumab is in progress and currently recruiting patients who are newly diagnosed with asymptomatic, high-risk CLL.
Dealing with a cancer diagnosis is difficult, but patients with MM have reason to be hopeful. Survival rates are on the rise, and a robust pipeline of promising immunotherapies and novel treatment options are in development.
Pharmacists have always been a vital member of the cancer care team, but the emergence of many new oral therapies is making their role in patient care a more prominent one.
The investigators created a panel of pseudotype viruses, which combined the HIV virus and SARS-CoV-2 spike protein.
The Novavax COVID-19 vaccine NVX-CoV2373 demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall in a phase 3 trial.
This month's products include a once-daily treatment for HIV-1, a topical suspension for scabies infestations, and more.
Susan Lang, MA, MBA, the CEO of XIL Health, discusses how pharmacies that have already been hard hit by the pandemic may be impacted if Pfizer goes through with their projected increased in COVID-19 vaccine prices.
The researchers analyzed patients with lung cancer before they underwent surgery and calculated their excess body weight using visceral fat index measured by CT scans.
Michael Holden, FRPharmS, FRSPH, associate director of Pharmacy Complete in the United Kingdom, discusses some of the key differences between the role of the pharmacist in the United Kingdom versus the United States.
Study results demonstrated consistent benefit across higher and lower-risk patients.
Researchers from Boston College and Microsoft Research may have found a way to combat these low percentages.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Innovative treatment options and new screening guidelines are transforming diagnosis and management of the disease.
Although the United States has surpassed the milestone of 100 million COVID-19 vaccinations, a study found that reaching 200 million will be significantly more challenging as vaccine hesitancy remains.
Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses for the prevention of herpes zoster in adults aged 50 years and older.
Here are 3 questions regarding pharmacists' role in a massive health care undertaking.
Adult patients with Clostrioides difficile infection who received hematopoietic stem cell transplant also benefitted from frontline medications fidaxomicin or oral vancomycin.
